TRPC1 and invasive breast carcinoma: TRPC1, TRPC5/6, TRPM4, TRPM7/8, TRPV1/2, TRPV4, and TRPV6 are strongly associated with progression and could be new therapeutic targets for breast invasive carcinoma (Chen et al., 2015; Saldías et al., 2021).